free online gin rummy games no download iNKT cell therapy "newcomer" - bispecific antibodies From 0:00 to 7:00 on June 14, 8 new confirmed cases in Beijing were all related to Xinfadi CD30/CD16A ...

The global placebo-controlled trial involves nearly 80 subjects with early diffuse cutaneous systemic sclerosis.

Zura Bio Limited ("Zura Bio"), a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today announced the launch of ...

In 17 heavily pretreated NSCLC EGFR mutant (EGFR mut) patients the combination shows an ORR of 24% and a DCR of 71%; tumor ...

Sinovac Biotech initiates phase ? trial on bivalent vaccine to treat hand foot and mouth disease: Beijing, China Tuesday, December 17, 2024, 18:00 Hrs [IST] Sinovac Biotech Ltd., ...

The Butantan Institute submitted a request to Anvisa (Brazil's National Health Surveillance Agency) on Monday (16) for the ...

Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today kicked off the enrollment for a Phase III clinical trial on a vaccine ...

Acimtamig is a monoclonal antibody commercialized by Affimed, with a leading Phase II program in Anaplastic Large Cell Lymphoma (ALCL).

The "Dengue Vaccine Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The dengue vaccine market ...

These proteins are highly expressed in most epithelial tumors. The tetravalent BL-B01D1 has two binding domains for distinct Growth Factor Receptors that drive cancer cell proliferation and survival.

AFM28, a bispecific, tetravalent innate cell engager (ICE ®) targeting CD123 and CD16A, achieved a 40% composite complete ...

AFM28, a bispecific, tetravalent innate cell engager (ICE®) targeting CD123 and CD16A, achieved a 40% composite complete remission rate (CRcR) at the highest dose level (300 mg) in heavily ...